ALLSCRIPTS HEALTHCARE SOLUTN's ticker is MDRX and the CUSIP is 01988P108. A total of 242 filers reported holding ALLSCRIPTS HEALTHCARE SOLUTN in Q4 2015. The put-call ratio across all filers is 0.37 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,011,249 | -9.2% | 305,270 | -12.9% | 0.01% | 0.0% |
| Q2 2023 | $4,417,521 | +7.2% | 350,597 | +11.1% | 0.01% | 0.0% |
| Q1 2023 | $4,119,141 | -38.0% | 315,643 | -16.3% | 0.01% | -44.4% |
| Q4 2022 | $6,648,304 | +5.1% | 376,888 | -9.3% | 0.01% | 0.0% |
| Q3 2022 | $6,325,217 | +25.0% | 415,313 | +21.7% | 0.01% | -30.8% |
| Q2 2022 | $5,061,000 | +170.1% | 341,259 | +310.1% | 0.01% | +225.0% |
| Q1 2022 | $1,874,000 | +110.1% | 83,212 | +72.2% | 0.00% | +100.0% |
| Q4 2021 | $892,000 | +34.1% | 48,324 | -2.8% | 0.00% | +100.0% |
| Q3 2021 | $665,000 | -36.2% | 49,739 | -11.6% | 0.00% | -50.0% |
| Q2 2021 | $1,042,000 | -18.3% | 56,291 | -33.7% | 0.00% | -33.3% |
| Q1 2021 | $1,275,000 | +2.7% | 84,926 | -1.2% | 0.00% | 0.0% |
| Q4 2020 | $1,242,000 | +110.9% | 85,991 | +18.8% | 0.00% | +200.0% |
| Q3 2020 | $589,000 | +24.5% | 72,394 | +3.5% | 0.00% | 0.0% |
| Q2 2020 | $473,000 | -17.3% | 69,927 | -14.0% | 0.00% | -50.0% |
| Q1 2020 | $572,000 | -26.5% | 81,275 | +2.6% | 0.00% | 0.0% |
| Q4 2019 | $778,000 | +5.4% | 79,252 | +17.9% | 0.00% | 0.0% |
| Q3 2019 | $738,000 | -7.1% | 67,201 | -1.6% | 0.00% | 0.0% |
| Q2 2019 | $794,000 | +19.4% | 68,310 | -2.1% | 0.00% | +100.0% |
| Q1 2019 | $665,000 | -5.8% | 69,744 | -4.7% | 0.00% | -50.0% |
| Q4 2018 | $706,000 | -30.2% | 73,214 | +3.1% | 0.00% | 0.0% |
| Q3 2018 | $1,011,000 | +16.9% | 70,979 | -1.5% | 0.00% | 0.0% |
| Q2 2018 | $865,000 | -11.6% | 72,049 | -9.0% | 0.00% | 0.0% |
| Q1 2018 | $978,000 | -17.2% | 79,189 | -2.5% | 0.00% | 0.0% |
| Q4 2017 | $1,181,000 | -0.6% | 81,187 | -2.8% | 0.00% | -33.3% |
| Q3 2017 | $1,188,000 | +11.5% | 83,498 | 0.0% | 0.00% | +50.0% |
| Q2 2017 | $1,065,000 | +47.5% | 83,498 | +46.6% | 0.00% | 0.0% |
| Q1 2017 | $722,000 | +21.1% | 56,937 | -2.5% | 0.00% | +100.0% |
| Q4 2016 | $596,000 | -29.0% | 58,378 | -8.5% | 0.00% | -50.0% |
| Q3 2016 | $840,000 | +8.0% | 63,776 | +4.1% | 0.00% | 0.0% |
| Q2 2016 | $778,000 | -8.8% | 61,240 | -5.1% | 0.00% | 0.0% |
| Q1 2016 | $853,000 | -14.5% | 64,552 | -0.5% | 0.00% | 0.0% |
| Q4 2015 | $998,000 | +18.8% | 64,882 | -4.2% | 0.00% | 0.0% |
| Q3 2015 | $840,000 | -11.4% | 67,707 | -2.2% | 0.00% | 0.0% |
| Q2 2015 | $948,000 | +7.5% | 69,254 | -6.0% | 0.00% | 0.0% |
| Q1 2015 | $882,000 | -6.4% | 73,702 | -0.1% | 0.00% | 0.0% |
| Q4 2014 | $942,000 | -11.4% | 73,769 | -6.9% | 0.00% | 0.0% |
| Q3 2014 | $1,063,000 | -16.8% | 79,237 | -0.4% | 0.00% | -33.3% |
| Q2 2014 | $1,277,000 | -3.0% | 79,570 | +8.9% | 0.00% | 0.0% |
| Q1 2014 | $1,317,000 | +7.2% | 73,041 | -8.1% | 0.00% | 0.0% |
| Q4 2013 | $1,229,000 | +4.1% | 79,460 | 0.0% | 0.00% | 0.0% |
| Q3 2013 | $1,181,000 | +19.1% | 79,460 | +3.7% | 0.00% | 0.0% |
| Q2 2013 | $992,000 | – | 76,630 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GLENHILL ADVISORS LLC | 10,507,149 | $138,799,000 | 8.42% |
| Tamarack Advisers, LP | 1,650,000 | $21,797,000 | 7.63% |
| Blue Harbour Group | 10,759,695 | $142,136,000 | 4.78% |
| BROADVIEW ADVISORS LLC | 1,095,800 | $14,476,000 | 2.08% |
| Rovida Advisors Inc. | 752,400 | $9,939,000 | 2.04% |
| Adirondack Research & Management Inc. | 361,259 | $4,772,000 | 1.73% |
| PARADIGM CAPITAL MANAGEMENT INC/NY | 1,104,400 | $14,589,000 | 1.70% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 14,401,161 | $190,239,000 | 1.62% |
| FULLER & THALER ASSET MANAGEMENT, INC. | 5,077,304 | $67,071,000 | 1.30% |
| Iguana Healthcare Management, LLC | 250,000 | $3,303,000 | 1.21% |